Dogan, S. E. Et Al. 2024. Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , no.10 , 1237-1239.

Dogan, S. E., Kuskonmaz, S. M., Koc, G., AYPAR, E., & Culha, C., (2024). Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , no.10, 1237-1239.

Dogan, Serife Et Al. "Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings," ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , no.10, 1237-1239, 2024

Dogan, Serife E. Et Al. "Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings." ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , no.10, pp.1237-1239, 2024

Dogan, S. E. Et Al. (2024) . "Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings." ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , no.10, pp.1237-1239.

@article{article, author={Serife Ezgi Dogan Et Al. }, title={Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings}, journal={ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS}, year=2024, pages={1237-1239} }